Free press releases distribution network?

Agency / Source: PharmaJet, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Very First FDA-Clearance Awarded to PharmaJet for a Needleless Intradermal Injection Device - First FDA-cleared needle-free injection alternative to needle-based “Mantoux” method - PharmaJet.com
Very First FDA-Clearance Awarded to PharmaJet for a Needleless Intradermal Injection Device

 

PRZOOM - /newswire/ - Golden, CO, United States, 2011/03/23 - First FDA-cleared needle-free injection alternative to needle-based “Mantoux” method - PharmaJet.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The U.S. Food and Drug Administration (FDA) has awarded PharmaJet 510(k) clearance to market a 0.1mL Intradermal (ID) Needle-free Injection System. Delivery to the intradermal tissue layer is the approach used for many vaccines, such as tuberculosis and rabies, for which ID delivery has proven efficacious. In addition, ID delivery is being explored for vaccines such as polio, influenza and many others in development. PharmaJet will now market the first FDA-cleared intradermal, needle-free alternative to the current needle-based “Mantoux” technique, which is time consuming, difficult for the healthcare provider to administer and painful for the patient to receive.

The intradermal layer is rich with cells that help stimulate the body’s immune response. With PharmaJet’s needle-free ID delivery into the same location as traditional needle/syringe injection, evidence suggests that the volume of some vaccines may be reduced by as much as 80% and still provide the appropriate immune protection. Intradermal delivery may allow for vaccine dosages to be stretched, providing significant savings in delivery costs and expanded coverage for vaccines in limited supply. This delivery system will enable routine use of lower-cost dose and volume-sparing strategies for mass vaccination and pandemic vaccine stockpile management.

“This is important technology and we are pleased to have the 1st FDA-cleared needle-free ID injection system”, stated James A. Bowman, President of PharmaJet Inc. “PharmaJet is proud to be the leader in needle-free injection technology, revolutionizing the way vaccines are delivered.”

In addition to this newly cleared ID device, PharmaJet currently markets an FDA-cleared, needle-free system for intramuscular (IM) and subcutaneous (SC) injection that delivers vaccines and liquid medications in a volume of 0.5mL. The PharmaJet single-use, auto-disabling, needle-free system delivers a narrow, high velocity fluid injection, which penetrates the skin in less than 1/3 of a second.

About PharmaJet, Inc. and Needle-free Injection Technology
PharmaJet’s needle-free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating needle-stick risk and the burden of sharps waste management. Further benefits of PharmaJet injectors include the potential for dose-sparing of vaccines, reducing the overall cost of vaccine delivery. The PharmaJet system (pharmajet.com) has been well received in the developed world, and is also extremely advantageous in the developing world due to its usability, affordability and inherent safety features.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: PharmaJet, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Very First FDA-Clearance Awarded to PharmaJet for a Needleless Intradermal Injection Device

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Regina Todd - PharmaJet.com 
410-209-2389 todd[.]pharmajet.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PharmaJet, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From PharmaJet, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today